Orphan drugs expenditure in the Netherlands in the period 2006–2012

BACKGROUND: The relatively low budget impact of orphan drugs is often used as an argument in reimbursement decisions. However, overall, the budget impact of orphan drugs can still be substantial. In this study, we assess the uptake and budget impact of orphan drugs in the Netherlands. METHODS: We ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanters, Tim A, Steenhoek, Adri, Hakkaart, Leona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195995/
https://www.ncbi.nlm.nih.gov/pubmed/25304026
http://dx.doi.org/10.1186/s13023-014-0154-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195995/
https://www.ncbi.nlm.nih.gov/pubmed/25304026
http://dx.doi.org/10.1186/s13023-014-0154-0

Ejemplares similares